Abstract
Obesity increases the risk of morbidity and mortality and reduces quality of life independent of age, sex or ethnicity. Leading health authorities recommend weight loss as a primary treatment strategy for obesity reduction—weight loss goals range from 5% to 10% of initial body weight. Intentional weight loss in most adults is associated with a reduction in many of the health complications of obesity. Nonetheless, emerging evidence supports the notion that a lifestyle-modification program characterized by an increase in physical activity and a balanced diet can reduce obesity and the risk of obesity-related comorbid conditions despite minimal or no weight loss. The benefits of such an approach include appreciable reductions in abdominal obesity, visceral fat and cardiometabolic risk factors, and increases in both skeletal muscle mass and cardiorespiratory fitness. Individuals with obesity face a serious challenge if they are to attain even modest weight loss in today's obesogenic environment. Clinicians could encourage positive lifestyle changes in their patients by counseling them that obesity and its associated health risks can be reduced in response to an increase in physical activity with or without weight loss.
Key Points
-
Leading organizations recommend 5–10% initial weight loss as the primary treatment strategy for obesity and related comorbid conditions
-
Physical activity combined with a healthy diet is associated with numerous improvements in metabolic risk factors, despite no or minimal weight loss (up to 3% of initial weight)
-
Exercise without weight loss is associated with marked reductions in abdominal obesity and increases in skeletal muscle mass, regardless of age or sex
-
Prospective analyses with long-term follow-up indicate that physically fit individuals have reduced risks of mortality and morbidity, independent of their body size
-
Health-care practitioners who assess obese patients should measure waist circumference, cardiorespiratory fitness and/or physical activity behaviors
-
Adoption of healthy lifestyle behaviors with minimal or no weight loss is a viable treatment strategy for obesity reduction, in particular abdominal obesity, and associated health risks
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
National Institutes of Health. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults-—The Evidence Report. Obes. Res. 6 (Suppl. 2), 51S–209S (1998).
World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation on Obesity (WHO, Geneva, 1998).
Lau, D. C. et al. 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary]. CMAJ 176, S1–S13 (2007).
Department of Health Central Office of Information. Obesity Care Pathway and Your Weight, Your Health [online] (2006).
Green, K. L. et al. Weight dissatisfaction and weight loss attempts among Canadian adults. Canadian Heart Health Surveys Research Group. CMAJ 157 (Suppl. 1), S17–S25 (1997).
Katzmarzyk, P. T. The Canadian obesity epidemic: an historical perspective. Obes. Res. 10, 666–674 (2002).
Flegal, K. M. et al. Prevalence and trends in obesity among US adults, 1999–2000. JAMA 288, 1723–1727 (2002).
Wang, Y. et al. Is China facing an obesity epidemic and the consequences? The trends in obesity and chronic disease in China. Int. J. Obes. (Lond.) 31, 177–188 (2007).
Miller, W. C. How effective are traditional dietary and exercise interventions for weight loss? Med. Sci. Sports Exerc. 31, 1129–1134 (1999).
Despres, J. P. et al. Treatment of obesity: need to focus on high risk abdominally obese patients. BMJ 322, 716–720 (2001).
Yusuf, S. et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case–control study. Lancet 366, 1640–1649 (2005).
Janiszewski, P. M. et al. Does waist circumference predict diabetes and cardiovascular disease beyond commonly evaluated cardiometabolic risk factors? Diabetes Care 30, 3105–3109 (2007).
Bigaard, J. et al. Waist circumference, BMI, smoking, and mortality in middle-aged men and women. Obes. Res. 11, 895–903 (2003).
Fujimoto, W. Y. et al. Visceral adiposity and incident coronary heart disease in Japanese-American men. The 10-year follow-up results of the Seattle Japanese-American Community Diabetes Study. Diabetes Care 22, 1808–1812 (1999).
Kuk, J. L. et al. Visceral fat is an independent predictor of all-cause mortality in men. Obes. Res. 14, 336–341 (2006).
Bray, G. A. Lifestyle and pharmacological approaches to weight loss: efficacy and safety. J. Clin. Endocrinol. Metab. 93, S81–S88 (2008).
Galbraith, W. B. et al. Weight loss and serum lipid changes in obese subjects given low calorie diets of varied cholesterol content. Ann. Intern. Med. 64, 268–275 (1966).
Keys, A. et al. The Biology of Human Starvation (The University of Minnesota Press, Minneapolis, 1950).
Walker, W. J. & Wier, J. A. Plasma cholesterol levels during rapid weight reduction. Circulation 3, 864–866 (1951).
Goldstein, D. J. Beneficial health effects of modest weight loss. Int. J. Obes. Relat. Metab. Disord. 16, 397–415 (1992).
Klein, S. Outcome success in obesity. Obes. Res. 9 (Suppl. 4), 354S–358S (2001).
Simonsen, M. K. et al. Intentional weight loss and mortality among initially healthy men and women. Nutr. Rev. 66, 375–386 (2008).
Sjostrom, L. et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N. Engl. J. Med. 357, 741–752 (2007).
Stevens, J. et al. The definition of weight maintenance. Int. J. Obes. (Lond.) 30, 391–399 (2006).
Janiszewski, P. M. & Ross, R. Physical activity in the management of visceral obesity and related cardiometabolic risk. In Abdominal Obesity and the Endocannabinoid System: From Basic Aspects to Clinical Management of Related Cardiometabolic Risk (Eds Despres, J. P. et al.) 89–104 (Informa Healthcare, New York, 2008).
Burstein, R. et al. Effect of an acute bout of exercise on glucose disposal in human obesity. J. Appl. Physiol. 69, 299–304 (1990).
Perseghin, G. et al. Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects. N. Engl. J. Med. 335, 1357–1362 (1996).
Widen, E. I. et al. Metformin normalizes nonoxidative glucose metabolism in insulin-resistant normoglycemic first-degree relatives of patients with NIDDM. Diabetes 41, 354–358 (1992).
Nolan, J. J. et al. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N. Engl. J. Med. 331, 1188–1193 (1994).
Musi, N. et al. AMP-activated protein kinase (AMPK) is activated in muscle of subjects with type 2 diabetes during exercise. Diabetes 50, 921–927 (2001).
Thompson, P. D. et al. The acute versus the chronic response to exercise. Med. Sci. Sports Exerc. 33, S438–S445 (2001).
Crouse, S. F. et al. Changes in serum lipids and apolipoproteins after exercise in men with high cholesterol: influence of intensity. J. Appl. Physiol. 79, 279–286 (1995).
Grandjean, P. W. et al. Influence of cholesterol status on blood lipid and lipoprotein enzyme responses to aerobic exercise. J. Appl. Physiol. 89, 472–480 (2000).
Kenney, M. J. & Seals, D. R. Postexercise hypotension. Key features, mechanisms, and clinical significance. Hypertension 22, 653–664 (1993).
Rueckert, P. A. et al. Hemodynamic patterns and duration of post-dynamic exercise hypotension in hypertensive humans. Med. Sci. Sports Exerc. 28, 24–32 (1996).
Shaw, K. et al. Exercise for overweight or obesity. Cochrane Database of Systematic Reviews Issue 4. Art. No.: CD003817. doi: 10.1002/14651858.CD003817.pub3 (2006).
Ready, A. E. et al. Walking program reduces elevated cholesterol in women postmenopause. Can. J. Cardiol. 11, 905–912 (1995).
Binder, E. F. et al. Effects of endurance exercise and hormone replacement therapy on serum lipids in older women. J. Am. Geriatr. Soc. 44, 231–236 (1996).
Dengel, D. R. et al. Distinct effects of aerobic exercise training and weight loss on glucose homeostasis in obese sedentary men. J. Appl. Physiol. 81, 318–325 (1996).
Mourier, A. et al. Mobilization of visceral adipose tissue related to the improvement in insulin sensitivity in response to physical training in NIDDM. Effects of branched-chain amino acid supplements. Diabetes Care 20, 385–391 (1997).
Boudou, P. et al. Effects of a single bout of exercise and exercise training on steroid levels in middle-aged type 2 diabetic men: relationship to abdominal adipose tissue distribution and metabolic status. Diabetes Metab. 26, 450–457 (2000).
Poehlman, E. T. et al. Effects of resistance training and endurance training on insulin sensitivity in nonobese, young women: a controlled randomized trial. J. Clin. Endocrinol. Metab. 85, 2463–2468 (2000).
Donnelly, J. E. et al. Effects of a 16-month randomized controlled exercise trial on body weight and composition in young, overweight men and women: the Midwest Exercise Trial. Arch. Intern. Med. 163, 1343–1350 (2003).
Irwin, M. L. et al. Effect of exercise on total and intra-abdominal body fat in postmenopausal women: a randomized controlled trial. JAMA 289, 323–330 (2003).
Short, K. R. et al. Impact of aerobic exercise training on age-related changes in insulin sensitivity and muscle oxidative capacity. Diabetes 52, 1888–1896 (2003).
Watkins, L. L. et al. Effects of exercise and weight loss on cardiac risk factors associated with syndrome X. Arch. Intern. Med. 163, 1889–1895 (2003).
Slentz, C. A. et al. Effects of the amount of exercise on body weight, body composition, and measures of central obesity: STRRIDE-—a randomized controlled study. Arch. Intern. Med. 164, 31–39 (2004).
O'Donovan, G. et al. Changes in cardiorespiratory fitness and coronary heart disease risk factors following 24 wk of moderate- or high-intensity exercise of equal energy cost. J. Appl. Physiol. 98, 1619–1625 (2005).
Stewart, K. J. et al. Exercise and risk factors associated with metabolic syndrome in older adults. Am. J. Prev. Med. 28, 9–18 (2005).
Sigal, R. J. et al. Effects of aerobic training, resistance training, or both on glycemic control in type 2 diabetes: a randomized trial. Ann. Intern. Med. 147, 357–369 (2007).
Shojaee-Moradie, F. et al. Exercise training reduces fatty acid availability and improves the insulin sensitivity of glucose metabolism. Diabetologia 50, 404–413 (2007).
Wilson, P. W. et al. Clustering of metabolic factors and coronary heart disease. Arch. Intern. Med. 159, 1104–1109 (1999).
Wing, R. R. et al. Long-term effects of modest weight loss in type II diabetic patients. Arch. Intern. Med. 147, 1749–1753 (1987).
Ross, R. et al. Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial. Ann. Intern. Med. 133, 92–103 (2000).
Ross, R. et al. Exercise-induced reduction in obesity and insulin resistance in women: a randomized controlled trial. Obes. Res. 12, 789–798 (2004).
DiPietro, L. et al. Moderate-intensity aerobic training improves glucose tolerance in aging independent of abdominal adiposity. J. Am. Geriatr. Soc. 46, 875–879 (1998).
Cuff, D. J. et al. Effective exercise modality to reduce insulin resistance in women with type 2 diabetes. Diabetes Care 26, 2977–2982 (2003).
Church, T. S. et al. Effects of different doses of physical activity on cardiorespiratory fitness among sedentary, overweight or obese postmenopausal women with elevated blood pressure: a randomized controlled trial. JAMA 297, 2081–2091 (2007).
Davidson, L. E. et al. Effects of exercise modality on insulin resistance and functional limitation in older adults: a randomized controlled trial. Arch. Intern. Med. 169, 122–131 (2009).
Lee, C. D. et al. Cardiorespiratory fitness, body composition, and all-cause and cardiovascular disease mortality in men. Am. J. Clin. Nutr. 69, 373–380 (1999).
Wei, M. et al. Relationship between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese men. JAMA 282, 1547–1553 (1999).
Sui, X. et al. Cardiorespiratory fitness and adiposity as mortality predictors in older adults. JAMA 298, 2507–2516 (2007).
Church, T. S. et al. Exercise capacity and body composition as predictors of mortality among men with diabetes. Diabetes Care 27, 83–88 (2004).
Weinstein, A. R. et al. The joint effects of physical activity and body mass index on coronary heart disease risk in women. Arch. Intern. Med. 168, 884–890 (2008).
Sui, X. et al. A prospective study of cardiorespiratory fitness and risk of type 2 diabetes in women. Diabetes Care 31, 550–555 (2008).
Orsini, N. et al. Combined effects of obesity and physical activity in predicting mortality among men. J. Intern. Med. 264, 442–451 (2008).
Ware, J. E. Jr & Sherbourne, C. D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med. Care 30, 473–483 (1992).
Kolotkin, R. L. et al. The relationship between health-related quality of life and weight loss. Obes. Res. 9, 564–571 (2001).
Blissmer, B. et al. Health-related quality of life following a clinical weight loss intervention among overweight and obese adults: intervention and 24 month follow-up effects. Health Qual. Life Outcomes 4, 43 (2006).
Hassan, M. K. et al. Obesity and health-related quality of life: a cross-sectional analysis of the US population. Int. J. Obes. Relat. Metab. Disord. 27, 1227–1232 (2003).
Bize, R. et al. Physical activity level and health-related quality of life in the general adult population: a systematic review. Prev. Med. 45, 401–415 (2007).
Atlantis, E. et al. An effective exercise-based intervention for improving mental health and quality of life measures: a randomized controlled trial. Prev. Med. 39, 424–434 (2004).
Bowen, D. J. et al. Randomized trial of exercise in sedentary middle aged women: effects on quality of life. Int. J. Behav. Nutr. Phys. Act. 3, 34 (2006).
Rejeski, W. J. et al. Obese, older adults with knee osteoarthritis: weight loss, exercise, and quality of life. Health Psychol. 21, 419–426 (2002).
Smith, S. C. Jr & Haslam, D. Abdominal obesity, waist circumference and cardio-metabolic risk: awareness among primary care physicians, the general population and patients at risk-—the Shape of the Nations survey. Curr. Med. Res. Opin. 23, 29–47 (2007).
Marshall, A. L. et al. Reliability and validity of a brief physical activity assessment for use by family doctors. Br. J. Sports Med. 39, 294–297 (2005).
Smith, B. J. et al. Screening for physical activity in family practice: evaluation of two brief assessment tools. Am. J. Prev. Med. 29, 256–264 (2005).
Calfas, K. J. et al. Practical nutrition assessment in primary care settings: a review. Am. J. Prev. Med. 18, 289–299 (2000).
Ross, R. et al. Effects of energy restriction and exercise on skeletal muscle and adipose tissue in women as measured by magnetic resonance imaging. Am. J. Clin. Nutr. 61, 1179–1185 (1995).
Ross, R. et al. Influence of diet and exercise on skeletal muscle and visceral adipose tissue in men. J. Appl. Physiol. 81, 2445–2455 (1996).
Lee, S. et al. Caffeine ingestion is associated with reductions in glucose uptake independent of obesity and type 2 diabetes before and after exercise training. Diabetes Care 28, 566–572 (2005).
Williamson, D. F. et al. Prospective study of intentional weight loss and mortality in never-smoking overweight US white women aged 40–64 years. Am. J. Epidemiol. 141, 1128–1141 (1995).
Wing, R. R. et al. Food provision vs structured meal plans in the behavioral treatment of obesity. Int. J. Obes. Relat. Metab. Disord. 20, 56–62 (1996).
Van Gaal, L. F. et al. The beneficial effects of modest weight loss on cardiovascular risk factors. Int. J. Obes. Relat. Metab. Disord. 21 (Suppl. 1), S5–S9 (1997).
Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 346, 393–403 (2002).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
R. Ross declares associations with the following companies: GlaxoSmithKline (speakers bureau), Roche (speakers bureau, grant/research support), Sanofi-Aventis (speakers bureau, grant/research support) and Theratechnologies (speakers bureau). A. J. Bradshaw declares no competing interests.
Rights and permissions
About this article
Cite this article
Ross, R., Bradshaw, A. The future of obesity reduction: beyond weight loss. Nat Rev Endocrinol 5, 319–325 (2009). https://doi.org/10.1038/nrendo.2009.78
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrendo.2009.78
This article is cited by
-
Konzept zur integrativen Schmerztherapie bei Gonarthrose unter Beachtung der Evidenz konservativer und komplementärer Verfahren
Der Schmerz (2023)
-
Effects of adding a diet intervention to exercise on hip osteoarthritis pain: protocol for the ECHO randomized controlled trial
BMC Musculoskeletal Disorders (2022)
-
Physical activity and fitness vs adiposity and weight loss for the prevention of cardiovascular disease and cancer mortality
International Journal of Obesity (2022)
-
Adipose Tissue Inflammation and Cardiovascular Disease: An Update
Current Diabetes Reports (2022)
-
Impact of CPAP treatment for obstructive sleep apnea on visceral adipose tissue: a meta-analysis of randomized controlled trials
Sleep and Breathing (2021)